V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008925 | 240005436 | null | 78.85 | Disease modification (D) | 2015-10-02 | 2015-10-08 | CETUXIMAB | N | Y | 240031958 | FLAG + IDARUBICIN |
| 240008926 | 240005436 | 1.67 | 83.35 | Curative (C) | 2018-10-13 | 2018-11-11 | CISPLATIN + ETOPOSIDE | 2 | N | 240031958 | CISPLATIN + FLUOROURACIL + RT |
| 240008927 | 240005437 | 1.74 | null | Palliative (P) | 2016-06-11 | 2016-07-08 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | 240032168 | CYCLOPHOSPHAMIDE |
| 240008928 | 240005437 | null | -1 | Palliative (P) | 2016-07-28 | 2016-08-14 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | N | N | 240032168 | BEVACIZUMAB |
| 240008929 | 240005438 | 1.93 | 89.5 | Curative (C) | 2015-03-23 | 2015-04-05 | CISPLATIN + GEMCITABINE | N | N | 240032233 | CHOEP |
| 240008930 | 240005438 | 1.58 | 68.5 | Curative (C) | 2016-02-10 | 2016-02-17 | BCG Intravesical | N | N | 240032233 | BEVACIZUMAB |
| 240008931 | 240005438 | 0 | 84.1 | Curative (C) | 2014-09-30 | 2014-10-02 | Oxaliplatin + Modified de Gramont | 02 | N | 240032233 | LENALIDOMIDE |
| 240008932 | 240005438 | 1.63 | 72.8 | Curative (C) | 2014-10-31 | 2014-11-15 | CISPLATIN + FLUOROURACIL + RT | N | N | 240032233 | GEMCARBO |
| 240008933 | 240005438 | 1.65 | 59.8 | Curative (C) | 2015-11-18 | 2015-11-20 | ABVD | N | N | 240032233 | METHOTREXATE INTRATHECAL |
| 240008934 | 240005438 | 1.51 | 78 | Curative (C) | 2015-04-25 | 2015-04-25 | FLUOROURACIL | 2 | N | 240032233 | BEVACIZUMAB + CARBO |
| 240008935 | 240005439 | 1.78 | 82.9 | Disease modification (D) | null | 2016-10-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | 240032654 | CHLORAMBUCIL + OFATUMUMAB |
| 240008936 | 240005440 | 1.64 | 73.3 | null | 2015-10-23 | 2015-10-29 | CISPLATIN + ETOPOSIDE | N | N | 240032911 | R-EPOCH |
| 240008937 | 240005441 | 1.6 | 68 | Palliative (P) | 2016-12-14 | 2016-12-17 | Bortezomib | 02 | N | 240032990 | POMALIDOMIDE |
| 240008938 | 240005441 | null | 53 | Adjuvant (A) | 2014-09-09 | 2014-09-10 | R-CHOEP | N | N | 240032990 | BEVACIZUMAB |
| 240008939 | 240005442 | 1.56 | 61.3 | Curative (C) | 2015-06-16 | 2015-07-30 | CHOEP - 21 days | null | N | 240033116 | CVP |
| 240008940 | 240005443 | 1.71 | 75 | Palliative (P) | 2015-08-02 | 2015-08-03 | Cisplatin + Topotecan | N | N | 240033201 | CLADRIBINE |
| 240008941 | 240005444 | 1.57 | 55.9 | Palliative (P) | 2015-09-27 | 2015-09-27 | Cisplatin + Topotecan | 2 | N | 240033210 | CISPLATIN + TOPOTECAN |
| 240008942 | 240010991 | 1.65 | 62.05 | Palliative (P) | 2018-04-28 | 2018-05-19 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | 240033248 | R-EPOCH |
| 240008943 | 240005445 | 1.71 | 69 | Curative (C) | 2013-11-14 | 2013-11-27 | Capecitabine + Cisplatin | N | N | 240033328 | CVD |
| 240008944 | 240005445 | 1.77 | null | Curative (C) | null | 2017-04-09 | Brentuximab Vedotin | null | N | 240033328 | GEMCITABINE + OXALIPLATIN |
| 240008945 | 240005445 | 1.63 | 68.6 | Palliative (P) | 2017-06-20 | 2017-06-26 | FEC 100 | 2 | N | 240033328 | CISPLATIN + ETOPOSIDE |
| 240008946 | 240005445 | 1.51 | null | Palliative (P) | 2018-05-05 | 2018-05-21 | ECX | N | N | 240033328 | R-GEM-P |
| 240008947 | 240005445 | 1.67 | 52.2 | Adjuvant (A) | 2015-02-12 | 2015-02-14 | DA-EPOCH-R | 02 | N | 240033328 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008948 | 240005445 | 1.75 | 89.1 | Curative (C) | 2014-05-12 | 2014-05-19 | REMODLB TRIAL | N | N | 240033328 | CVP |
| 240008949 | 240005446 | 1.62 | 47.5 | null | 2017-07-29 | 2017-08-03 | FLUDARABINE | N | N | 240033639 | CISPLATIN + ETOPOSIDE |
| 240008950 | 240005447 | 1.85 | 97.04 | Palliative (P) | 2016-04-17 | 2016-04-20 | ETOPOSIDE | N | null | 240033656 | PMITCEBO-R |
| 240008951 | 240005448 | 1.56 | 60.2 | Neo-adjuvant (N) | 2015-07-19 | 2015-07-19 | IPILIMUMAB + NIVOLUMAB | 99 | N | 240033681 | PEMBROLIZUMAB |
| 240008952 | 240005449 | 1.83 | 80 | Disease modification (D) | 2018-10-18 | 2018-10-31 | Cladribine (subcut) 5 days | 02 | N | 240033722 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008953 | 240005450 | 1.59 | 73.1 | Curative (C) | null | 2016-08-20 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINBLASTINE | N | N | 240033853 | FLUDARABINE + MELPHALAN |
| 240008954 | 240005451 | 1.68 | 55.9 | Adjuvant (A) | 2012-05-19 | 2014-04-16 | FLUDARABINE | N | N | 240033903 | FCR |
| 240008955 | 240005452 | 1.51 | null | null | 2017-12-06 | 2017-12-22 | Fludarabine + Melphalan RIC Allo | N | N | 240033978 | FCR |
| 240008956 | 240005453 | 1.76 | 32.8 | Curative (C) | 2014-12-21 | 2014-12-30 | Oxaliplatin + Modified de Gramont | N | N | 240034000 | ECX |
| 240008957 | 240010993 | 1.73 | 85.6 | Disease modification (D) | 2013-09-24 | 2013-10-08 | IBRUTINIB | N | N | 240034037 | CLADRIBINE + RITUXIMAB |
| 240008958 | 240010993 | 1.66 | 57 | Curative (C) | 2015-08-06 | 2015-08-07 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 240034037 | BCG |
| 240008959 | 240010993 | 1.72 | 64.9 | Curative (C) | null | 2015-03-23 | CARBOPLATIN + GEMCITABINE | N | N | 240034037 | CISPLATIN + FLUOROURACIL |
| 240008960 | 240005454 | 1.6 | 54.5 | Palliative (P) | 2016-06-19 | 2016-06-24 | Cisplatin + Topotecan | 02 | N | 240034282 | MITOXANTRONE |
| 240008961 | 240005454 | 1.6 | 81 | Curative (C) | 2014-02-16 | 2014-02-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240034282 | CAPECITABINE + RT |
| 240008962 | 240013672 | 1.8 | null | Curative (C) | 2015-11-03 | 2015-11-29 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 240034474 | R-EPOCH |
| 240008963 | 240005455 | null | 72.5 | null | 2017-09-15 | 2017-09-16 | BCG Intravesical | N | N | 240034520 | CVP |
| 240008964 | 240010995 | null | 85.5 | null | 2015-11-16 | 2015-11-16 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240034631 | GDP |
| 240008965 | 240005456 | 1.71 | 77 | Not known (9) | 2017-10-30 | 2017-10-31 | ABVD | 02 | N | 240034638 | CVP |
| 240008966 | 240005456 | 1.68 | 89.8 | Curative (C) | 2018-07-27 | 2018-07-27 | CHOEP - 21 days | 2 | N | 240034638 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008967 | 240005457 | 1.69 | 66 | Palliative (P) | 2018-11-10 | 2018-11-11 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | N | 240034719 | CISPLATIN + VINORELBINE |
| 240008968 | 240005458 | 1.81 | 87 | Curative (C) | 2014-08-18 | 2014-08-18 | Cytarabine Low Dose | N | N | 240034830 | CISPLATIN + GEMCITABINE |
| 240008969 | 240005459 | null | 62.5 | Palliative (P) | 2017-07-28 | 2017-08-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | Y | 240034892 | CISPLATIN + ETOPOSIDE |
| 240008970 | 240005459 | 1.7 | 65.5 | Palliative (P) | 2019-02-03 | 2019-02-17 | DA-EPOCH-R | 02 | N | 240034892 | BEVACIZUMAB |
| 240008971 | 240005459 | 1.61 | 64 | null | 2016-01-07 | 2016-01-11 | ABVD | 02 | N | 240034892 | FEC |
| 240008972 | 240005460 | 1.58 | 58.8 | Not known (9) | 2018-04-13 | 2018-04-13 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | Y | N | 240035260 | PMITCEBO-R |
| 240008973 | 240010998 | 1.62 | 47 | Palliative (P) | 2018-03-03 | 2018-03-03 | R CODOX M | 2 | N | 240035263 | CISPLATIN + FLUOROURACIL + RT |
| 240008974 | 240010998 | null | null | Palliative (P) | 2015-05-27 | 2015-05-30 | Cytarabine HD + Methotrexate HD | 2 | N | 240035263 | NORDIC |